{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:09:00Z","timestamp":1759334940404,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaad.2020.02.049","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:47:00Z","timestamp":1582292820000},"page":"e249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to: \u201cThe age of procalcitonin: Potential pitfalls in critically ill patients with SJS\/TEN. A comment on \u2018Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients\u2019\u201d"],"prefix":"10.1016","volume":"82","author":[{"given":"Hui Kai","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.02.049_bib1","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jaad.2020.01.086","article-title":"The age of procalcitonin: potential pitfalls in critically ill patients with SJS\/TEN. A comment on \u201cRisk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cohort study of 176 patients","volume":"82","author":"Jacobsen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.02.049_bib2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaad.2019.05.096","article-title":"Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cohort study of 176 patients","volume":"81","author":"Koh","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.02.049_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","article-title":"The diagnostic accuracy of procalcitonin for bacteremia: a systematic review and meta-analysis","volume":"21","author":"Hoeboer","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2020.02.049_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/cid\/ciu732","article-title":"Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy","volume":"59","author":"Grace","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2020.02.049_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.diagmicrobio.2016.07.015","article-title":"Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury","volume":"86","author":"Takahashi","year":"2016","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220302905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220302905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:05Z","timestamp":1759273025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220302905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0190962220302905"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.049","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to: \u201cThe age of procalcitonin: Potential pitfalls in critically ill patients with SJS\/TEN. A comment on \u2018Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients\u2019\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.01.086","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}